Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
aldesleukin (Proleukin) (1 trial)
cyclophosphamide (cytoxan) (1 trial)
pa9159 (2 trials)
pd-1 knockout t cells (1 trial)
Esophageal Neoplasms (Phase 2)
Trials (3 total)
Trial APIs (4 total)